Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
BioTime, Inc. (NYSE MKT: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, today announced that Chief Executive Officer Michael D. West, PhD will present at the USC Minisymposium: Musculoskeletal Development and Repair conference at the Keck School of Medicine, the University of Southern California, on Monday, May 20, 2013. Dr. West’s presentation titled “Derivation of chondrogenic progenitor lines from human embryonic stem cells” is scheduled for 8:30 am PDT.
Help employers find you! Check out all the jobs and post your resume.
BioTime, Inc. (NYSE MKT: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, today announced that Chief Executive Officer Michael D. West, PhD will present at the USC Minisymposium: Musculoskeletal Development and Repair conference at the Keck School of Medicine, the University of Southern California, on Monday, May 20, 2013. Dr. West’s presentation titled “Derivation of chondrogenic progenitor lines from human embryonic stem cells” is scheduled for 8:30 am PDT.
Help employers find you! Check out all the jobs and post your resume.
